» Articles » PMID: 6159417

IgG or IgM Monoclonal Antibodies Reactive with Different Determinants on the Molecular Complex Bearing Lyt 2 Antigen Block T Cell-mediated Cytolysis in the Absence of Complement

Overview
Journal J Immunol
Date 1980 Dec 1
PMID 6159417
Citations 260
Authors
Affiliations
Soon will be listed here.
Abstract

Five rat monoclonal antibodies have been derived that express specificities for determinants present on the molecular complex bearing the Lyt 2 antigen. SDS-polyacrylamide gel electrophoresis of 125I-labeled polypeptides precipitated by each of these antibodies reveal 3 components (150,000, 75,000, and 33,000 daltons), and 2 components (44,000 and 33,000 daltons) when analyzed under nonreducing and reducing conditions, respectively. Two of these antibodies are IgG and are specific for the Lyt 2.2 determinant; the other 3 are IgM and react with determinants other than Lyt 2.2, which are nonpolymorphic. Each of the 5 antibodies can block the cytolytic activities of 5-day MLC cells or of cloned cytolytic T cells in the absence of C. Treatment of responding spleen cells with any of these antibodies and C inhibits the generation of cytolytic activity in MLC.

Citing Articles

Homeostasis of Naive and Memory T Lymphocytes.

Kawabe T, Yi J, Sprent J Cold Spring Harb Perspect Biol. 2021; 13(9).

PMID: 33753403 PMC: 8411951. DOI: 10.1101/cshperspect.a037879.


Dermal IRF4+ dendritic cells and monocytes license CD4+ T helper cells to distinct cytokine profiles.

Hilligan K, Tang S, Hyde E, Roussel E, Mayer J, Yang J Nat Commun. 2020; 11(1):5637.

PMID: 33159073 PMC: 7647995. DOI: 10.1038/s41467-020-19463-9.


MSP22.8 is a protease inhibitor-like protein involved in shell mineralization in the edible mussel .

Calvo-Iglesias J, Perez-Estevez D, Gonzalez-Fernandez A FEBS Open Bio. 2017; 7(10):1539-1556.

PMID: 28979842 PMC: 5623705. DOI: 10.1002/2211-5463.12286.


CD4 T cells require either B cells or CD8 T cells to control spread and pathogenesis of a neurotropic infection.

Solomos A, ORegan K, Rall G Virology. 2016; 499:196-202.

PMID: 27677156 PMC: 5102754. DOI: 10.1016/j.virol.2016.09.013.


Protection from tumor recurrence following adoptive immunotherapy varies with host conditioning regimen despite initial regression of autochthonous murine brain tumors.

Cozza E, Cooper T, Budgeon L, Christensen N, Schell T Cancer Immunol Immunother. 2014; 64(3):325-36.

PMID: 25408469 PMC: 4344424. DOI: 10.1007/s00262-014-1635-7.